CPT 87539: HIV-2 Viral Load (Quantitative RNA) Test

CPT code 87539 is a molecular diagnostic laboratory code for quantifying HIV‑2 viral RNA (viral load) in a patient specimen. Nationally, viral load testing for HIV‑2 is an important component of HIV clinical management, guiding monitoring of disease progression and response to therapy. Accurate coding of this test ensures appropriate clinical tracking and supports laboratory reimbursement and reporting.

Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical purpose of the test, the typical service setting, and which major payers commonly cover this service. The publication summarizes national benchmarks and coverage patterns where available, highlights relevant policy updates affecting lab reimbursement, and provides clinical context about when HIV‑2 viral load testing is indicated. Where specific input data are unavailable, the text notes that data were not provided.

This analysis is written for a national audience of clinicians, laboratory managers, and billing professionals seeking a clear, practical reference about CPT code 87539, its clinical role, and payer coverage considerations.

Billing Code Overview

CPT code 87539 describes a laboratory test that measures the amount of HIV‑2 viral RNA (viral load) in a patient specimen. This molecular diagnostic assay quantifies the level of HIV‑2 present and is used to monitor infection and the effectiveness of antiretroviral therapy.

Service Type: Molecular diagnostic viral load testing

Typical Site of Service: Clinical laboratory or hospital laboratory

Clinical Context

A 42-year-old patient with known HIV infection attends an outpatient infectious disease clinic for routine monitoring. The clinician orders an HIV-2 quantitative viral load test to assess virologic suppression and guide antiretroviral therapy decisions. The patient presents to the clinic or affiliated phlebotomy laboratory; a blood specimen (plasma) is collected following standard venipuncture protocols and sent to a molecular diagnostics laboratory. The laboratory performs nucleic acid amplification testing to quantify HIV-2 RNA, reports copies per milliliter, and returns results to the ordering clinician. Results inform clinical decisions such as adherence counseling, resistance testing, regimen change, or continued monitoring.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the physician interpretation/reporting portion separate from the technical lab processing if applicable in split billing arrangements.
`TC`	Technical component	Use when billing only the laboratory/test processing portion and not the professional interpretation.

Taxonomy Code	Specialty	Notes
207RH0000X	Infectious Disease	Clinicians who order HIV viral load testing and manage antiretroviral therapy.
207K00000X	Internal Medicine	Primary care physicians monitoring chronic HIV infection and ordering surveillance testing.
208D00000X	Pathology and Laboratory Medicine	Laboratory directors and pathologists overseeing molecular diagnostic testing and result validation.
363L00000X	Clinical Laboratory Scientist	Professionals performing and supervising molecular assays in the lab.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`B21.0`	HIV disease resulting in mycobacterial infection	Represents advanced HIV disease where HIV-2 viral load monitoring informs management of opportunistic infections.
`B20`	Human immunodeficiency virus [HIV] disease	General code for HIV infection; viral load quantification is central to monitoring disease activity and therapy.
`Z21`	Asymptomatic human immunodeficiency virus [HIV] infection status	Used for patients with HIV infection without symptoms; periodic HIV-2 viral load testing monitors suppression.
`R75`	Inconclusive laboratory evidence of human immunodeficiency virus [HIV]	May prompt additional testing including type-specific viral load assays to clarify infection status.
`B25.9`	Cytomegaloviral disease, unspecified	Example opportunistic infection in HIV-infected patients; viral load informs immunosuppression level and risk.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`87457`	Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification	Performed when HIV-1 viral load testing is required in parallel or differential evaluation between HIV-1 and HIV-2.
`87536`	Infectious agent detection by nucleic acid (DNA or RNA); HIV-1/HIV-2, single assay, qualitative	May be used for initial screening or differentiation before or alongside quantitative testing.
`86701`	Antibody; HIV-1, enzyme immunoassay	Often performed as initial serologic screening before ordering type-specific viral load testing.
`87538`	Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, amplified probe technique, quantitative	Alternative quantitative method for HIV-1 that may be ordered in the same diagnostic workflow.
`87252`	Smear, primary source with interpretation; Gram stain and culture/smear related tests	Not directly testing HIV, but may be done in clinical evaluation of opportunistic infections in HIV-infected patients.

OpenPayer

Summary & Overview